Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: No consistent evidence for an association in the nordic population

Research output: Contribution to journalJournal articleResearchpeer-review

  • Peter Saetre
  • Jakob Grove
  • Anders Børglum
  • Ole Mors
  • Werge, Thomas
  • Ole A Andreassen
  • Maria Vares
  • Ingrid Agartz
  • Lars Terenius
  • Erik G Jönsson
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme involved in metabolic pathways of importance for nucleotide synthesis and methylation of DNA, membranes, proteins and lipids. The MTHFR gene includes a common polymorphism (rs1801133 or C677T), which is associated with enzyme activity. The T-allele of the C677T polymorphism has been associated with earlier age at onset of schizophrenia in a Scandinavian population, although no association was found in replication attempts in other populations. Extending the study to five Nordic samples consisting of 2,198 patients with schizophrenia, including the original Scandinavian samples, there was no significant association between MTHFR C677T polymorphism and age at onset in schizophrenia. The present results do not suggest that the investigated MTHFR polymorphism has any significant influence on age at onset of schizophrenia in the Nordic population. © 2012 Wiley Periodicals, Inc.
Original languageEnglish
JournalAmerican Journal of Medical Genetics. Part B: Neuropsychiatric Genetics
Volume159B
Issue number8
Pages (from-to)981-6
Number of pages6
ISSN1552-4841
DOIs
Publication statusPublished - Dec 2012

ID: 48611451